1
|
Sands JM, Milan MSD, Oxnard GR. Blood-Based Disease Assessment in SCLC: A Perpetual Proof of Concept or a Clinically Important Tool? J Thorac Oncol 2020; 15:163-165. [PMID: 32127182 DOI: 10.1016/j.jtho.2019.11.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2019] [Accepted: 11/15/2019] [Indexed: 10/25/2022]
Affiliation(s)
- Jacob M Sands
- Dana-Farber Cancer Institute, Boston, Massachusetts.
| | | | | |
Collapse
|